Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Randomised, double-blinded placebo controlled trial of the use of tocolysis for a repeat external cephalic version after a failed version for breech presentation at term
ISRCTN ISRCTN31614268
ClinicalTrials.gov identifier
Public title Randomised, double-blinded placebo controlled trial of the use of tocolysis for a repeat external cephalic version after a failed version for breech presentation at term
Scientific title
Acronym N/A
Serial number at source SEO093
Study hypothesis To determine the optimum protocol for performing external cephalic version for breech presentation at term. Null hypothesis: that tocolysis for a repeat external cephalic version (ECV) after a failed ECV does not increase the success rates of ECV
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Childbirth
Participants - inclusion criteria 1. Women with suspected or confirmed breech presentation at >36 weeks gestation
2. Have undergone a single (<15 mins) unsuccessful attempt at external cephalic version without tocolysis at 37 or more weeks' gestation
Participants - exclusion criteria 1. Abnormal cardiotocograph
2. Cardiac disease
3. Pre-existing or gestational diabetes
4. Hypertension;
5. Pre-existing indication for caesarian section
6. Suspected unstable lie
7. Pre-eclampsia
8. recent (<4 weeks) antepartum haemorrhage
9. suspected fetal compromise
10. rhesus immunisation
Anticipated start date 06/04/2000
Anticipated end date 06/04/2002
Status of trial Completed
Patient information material
Target number of participants 124 (added 12/01/10, see publication)
Interventions 1. 50 mg ritodrine hydrochloride infusion
2. 17 ml dextrose saline solution infusion
Primary outcome measure(s) 1. Incidence of cephalic presentation at delivery
2. Subjective patient assessment of discomfort
3. Incidence of caesarian section
4. Length of hospital stay
5. Incidence of neonatal Apgar scores <7 at 5 minutes
6. Incidence of neonatal intensive care admission
Secondary outcome measure(s) Not provided at time of registration
Sources of funding NHS Executive South East (UK)
Trial website
Publications 2005 results in http://www.ncbi.nlm.nih.gov/pubmed/15842288
Contact name Mr  Lawrence  Impey
  Address Level 4
The Women's Centre
John Radcliffe Hospital
Headley Way
Headington
  City/town Oxford
  Zip/Postcode OX3 9DU
  Country United Kingdom
  Tel +44 (0)1865741166 Ex 21408/21624
  Email LWMI@compuserve.com
Sponsor NHS R&D Regional Programme Register - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.doh.gov.uk
Date applied 23/01/2004
Last edited 12/01/2010
Date ISRCTN assigned 23/01/2004
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central